Cargando…

Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort Study

Aim: To evaluate the prognostic value of plasma big endothelin-1 level in the context of three-vessel disease (TVD) with heavy atherosclerotic burden. Methods: A total of 6,150 patients with TVD and available big endothelin-1 data were included in the study. Participants were divided into two groups...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ce, Tian, Jian, Jiang, Lin, Xu, Lianjun, Liu, Junhao, Zhao, Xueyan, Feng, Xinxing, Wang, Dong, Zhang, Yin, Sun, Kai, Xu, Bo, Zhao, Wei, Hui, Rutai, Gao, Runlin, Yuan, Jinqing, Song, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6845695/ https://www.ncbi.nlm.nih.gov/pubmed/30828008 http://dx.doi.org/10.5551/jat.47324

Ejemplares similares

Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease
por: Li, Tianyu, et al.
Publicado: (2022)

Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel disease
por: Yuan, Deshan, et al.
Publicado: (2021)

Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China
por: Zhao, Xueyan, et al.
Publicado: (2021)

Prediabetes and long‐term outcomes in patients with three‐vessel coronary artery disease: A large single‐center cohort study
por: Yuan, Deshan, et al.
Publicado: (2020)

Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study
por: Zeng, Guyu, et al.
Publicado: (2023)

Susceptible gene polymorphism in patients with three-vessel coronary artery disease
por: Liu, Ru, et al.
Publicado: (2020)

HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins
por: Li, Jiawen, et al.
Publicado: (2023)

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
por: Fan, Peng, et al.
Publicado: (2021)

Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease
por: Zhao, Xueyan, et al.
Publicado: (2021)

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
por: Yuan, Deshan, et al.
Publicado: (2021)

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention
por: Zhao, Xueyan, et al.
Publicado: (2019)

Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023)

Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention
por: Jia, Sida, et al.
Publicado: (2020)

Association between cumulative lipoprotein(a) exposure and adverse cardiovascular outcomes in patients with prediabetes or diabetes
por: Wang, Peizhi, et al.
Publicado: (2023)

The Value of Big Endothelin-1 in the Assessment of the Severity of Coronary Artery Calcification
por: Wang, Fang, et al.
Publicado: (2018)

Association of Big Endothelin-1 with Coronary Artery Calcification
por: Qing, Ping, et al.
Publicado: (2015)

Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
por: Kostov, Krasimir, et al.
Publicado: (2021)

Big Endothelin-1 as a Predictor of Reverse Remodeling and Prognosis in Dilated Cardiomyopathy
por: Feng, Jiayu, et al.
Publicado: (2023)

Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study
por: Yuan, Deshan, et al.
Publicado: (2021)

Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease
por: Li, Xinsheng, et al.
Publicado: (2023)

Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma
por: Jiao, Wenjie, et al.
Publicado: (2008)

Associations of big endothelin-1 and C-reactive protein in atrial fibrillation
por: Zheng, Li-Hui, et al.
Publicado: (2016)

Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended on Dual Antiplatelet Therapy
por: Cui, Wen, et al.
Publicado: (2023)

Association of prognostic nutritional index level and diabetes status with the prognosis of coronary artery disease: a cohort study
por: Li, Tianyu, et al.
Publicado: (2023)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study
por: Li, Tianyu, et al.
Publicado: (2022)

Plasma big endothelin-1 is an effective predictor for ventricular arrythmias and end-stage events in primary prevention implantable cardioverter- defibrillator indication patients
por: LI, Xiao-Yao, et al.
Publicado: (2020)

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort
por: Wang, Peizhi, et al.
Publicado: (2022)

Evaluation of Urinary Big Endothelin-1 in Feline Spontaneous CKD
por: Giraldi, Marco, et al.
Publicado: (2020)

5-Year Clinical Outcomes of Successful Recanalisation for Coronary Chronic Total Occlusions in Patients With or Without Type 2 Diabetes Mellitus
por: Wang, Peizhi, et al.
Publicado: (2021)

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021)

Plasma endothelin-1-related peptides as the prognostic biomarkers for heart failure: A PRISMA-compliant meta-analysis
por: Zhang, Cheng-Lin, et al.
Publicado: (2017)

Association between inflammation, body mass index, and long-term outcomes in patients after percutaneous coronary intervention: A large cohort study
por: Zeng, Guyu, et al.
Publicado: (2023)

Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
por: Lyu, Si-qi, et al.
Publicado: (2022)

Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy
por: Song, Changpeng, et al.
Publicado: (2019)

Elevated Plasma Big Endothelin-1 at Admission Is Associated With Poor Short-Term Outcomes in Patients With Acute Decompensated Heart Failure
por: Mo, Ran, et al.
Publicado: (2021)

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

Plasma endothelin-1 and single nucleotide polymorphisms of endothelin-1 and endothelin type A receptor genes as risk factors for normal tension glaucoma
por: Kosior-Jarecka, Ewa, et al.
Publicado: (2016)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nkdodngpjd3vuu57psa8gifvst